Clinical Efficacy of Vestibular Rehabilitation Training Combined with Medical Wisdom Platform on Vertigo Caused by Vestibular Neuritis.

OBJECTIVE: The clinical manifestation of vertigo caused by vestibular neuritis is acute and persistent vertigo, accompanied by nausea, vomiting, and dizziness. Low-dose glucocorticoid therapy is recommended in the acute phase, while drug therapy is not recommended in the recovery phase. Therefore, it is of certain clinical value to explore other treatment options. This study hopes to better fill the current research gap in non-drug treatment of vertigo caused by vestibular neuritis.

METHODS: The medical data of 96 patients with vertigo caused by vestibular neuritis in our hospital from May 2019 to May 2021 were retrospectively analyzed. According to different treatment methods, they were divided into the control group (routine treatment regimen) and the experimental group (vestibular rehabilitation training combined with the medical wisdom platform), with 48 cases in each group, and the clinical efficacy of the two groups was compared.

RESULTS: The total effective rate of treatment was 95.83% in the experimental group, which was significantly higher than 79.17% in the control group (χ2 = 6.095, P = .014). In the two groups, the scores of dizziness handicap inventory (DHI) and vestibular symptom index (VSI) decreased. In contrast, the scores of Tinetti performance-oriented mobility assessment (POMA) and functional independence measure (FIM) increased after treatment. After treatment, the experimental group had significantly lower DHI score (t = 12.942, P < .001), distinctly higher POMA score (t = 9.940, P < .001), overtly lower VSI score (t = 8.783, P < .001), and notably higher FIM score than the control group (t = 12.649, P < .001).

CONCLUSION: The application of vestibular rehabilitation training combined with the medical wisdom platform is beneficial to patients with vertigo caused by vestibular neuritis, which provides reference for the subsequent treatment of this disease and has a certain clinical promotion value.